İçeriğe geç

Orak Hücreli Anemi

Tıkayıcı Damar Hastalıklarının Tedavisi ve Akut Göğüs Sendromu

Ağrı Tedavisi

What is the best pharmacologic treatment for sickle cell disease pain crises? (yeni pencere açar)

Baker M, Hafner JW.

Kaynak‎: Ann Emerg Med 2012;59(6):515-6.

İndeks‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (yeni pencere açar)

Update on pain management in sickle cell disease. (yeni pencere açar)

Ballas SK.

Kaynak‎: Hemoglobin 2011;35(5-6):520-9.

İndeks‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (yeni pencere açar)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (yeni pencere açar)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Kaynak‎: Thromb Haemost 2007;98(2):392-6.

İndeks‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (yeni pencere açar)

Hidrasyonun Sağlanması (Sıvı Tedavisi)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (yeni pencere açar)

Okomo U, Meremikwu MM.

Kaynak‎: Cochrane Database Syst Rev 2012;(6):CD005406.

İndeks‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (yeni pencere açar)

Oksijen Takviyesi

Guidelines for the management of the acute painful crisis in sickle cell disease. (yeni pencere açar)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Kaynak‎: Br J Haematol 2003;120(5):744-52.

İndeks‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (yeni pencere açar)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (yeni pencere açar)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Kaynak‎: Diving Hyperb Med 2012;42(2):82-4.

İndeks‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (yeni pencere açar)

Antibiyotik ve Solunum Sistemi Tedavisi

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (yeni pencere açar)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Kaynak‎: Hemoglobin 2004;28(2):85-102.

İndeks‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (yeni pencere açar)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (yeni pencere açar)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Kaynak‎: N Engl J Med 1995;333(11):699-703.

İndeks‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (yeni pencere açar)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (yeni pencere açar)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Kaynak‎: J Investig Med 2008;56(8):1023-7.

İndeks‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (yeni pencere açar)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (yeni pencere açar)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Kaynak‎: N Engl J Med 2000;342(25):1855-65.

İndeks‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (yeni pencere açar)